{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-038014","form_type":"8-K","ticker":"EPC","cik":"0001096752","company_name":"EDGEWELL PERSONAL CARE Co","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.211170+00:00","generated_at":"2026-06-08T06:04:24.400853+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Edgewell Q4 net sales $534M (-0.5% YoY); FY23 adj EPS $2.56 (+14% CC); FY24 guides 2-4% organic growth","bullets":["GAAP diluted EPS Q4 $0.57, FY23 $2.18; adjusted EPS Q4 $0.72, FY23 $2.56 (up 14% constant currency YoY).","Full year organic net sales growth of 4.3%; Q4 organic sales declined 1.9%.","Returned $107M to shareholders via $75M buybacks and $32M in dividends; net debt leverage 3.4x.","Board declared quarterly cash dividend of $0.15 per share on November 2, 2023.","FY2024 outlook: organic net sales growth ~2-4%, adjusted EPS growth ~7% (15% constant currency)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-038014","json":"https://secwatch.observer/filing/0001628280-23-038014.json","markdown":"https://secwatch.observer/filing/0001628280-23-038014.md","text":"https://secwatch.observer/filing/0001628280-23-038014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096752/000162828023038014/0001628280-23-038014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096752/000162828023038014/epc-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:04:24.400853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2894faa8b42fb81f8777240187c0a53851361b08","claim":"EDGEWELL PERSONAL CARE Co reported fourth quarter and fiscal year ended September 30, 2023 results: revenue $534.1 million, EPS $0.57. Guidance initiated.","evidence_excerpt":"its fourth fiscal quarter 2023 and fiscal year ended, September 30, 2023 , and provided its financial outlook for fiscal 2024 . Executive Summary • Fourth quarter net sales were $534.1 million, a decrease of 0.5% compared to the prior year period. Full year net sales were $2,251.6 million, an increase of 3.7% compared to the prior year. • Organic net sales decreased","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1096752/000162828023038014/0001628280-23-038014-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and fiscal year ended September 30, 2023"},{"label":"Revenue","value":"$534.1 million"},{"label":"EPS","value":"$0.57"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}